A detailed history of Gw&K Investment Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 431 shares of NVO stock, worth $45,371. This represents 0.0% of its overall portfolio holdings.

Number of Shares
431
Previous 431 -0.0%
Holding current value
$45,371
Previous $62,000 17.74%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$122.71 - $146.91 $736 - $881
-6 Reduced 1.37%
431 $62,000
Q1 2024

May 08, 2024

BUY
$102.11 - $135.92 $11,334 - $15,087
111 Added 34.05%
437 $56,000
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $12,549 - $27,536
138 Added 73.4%
326 $30,000
Q2 2023

Aug 09, 2023

BUY
$155.98 - $172.65 $25,424 - $28,141
163 Added 652.0%
188 $30,000
Q4 2022

Feb 10, 2023

SELL
$102.55 - $135.33 $2,256 - $2,977
-22 Reduced 46.81%
25 $3,000
Q1 2022

May 09, 2022

SELL
$93.1 - $112.54 $1.1 Million - $1.33 Million
-11,858 Reduced 99.61%
47 $5,000
Q4 2021

Feb 11, 2022

SELL
$95.88 - $117.08 $550,926 - $672,741
-5,746 Reduced 32.55%
11,905 $1.33 Million
Q3 2021

Nov 10, 2021

BUY
$84.42 - $106.62 $19,754 - $24,949
234 Added 1.34%
17,651 $1.7 Million
Q2 2021

Aug 10, 2021

BUY
$67.66 - $84.76 $62,720 - $78,572
927 Added 5.62%
17,417 $1.46 Million
Q1 2021

May 11, 2021

BUY
$67.06 - $75.82 $161,011 - $182,043
2,401 Added 17.04%
16,490 $1.11 Million
Q4 2020

Feb 05, 2021

BUY
$63.89 - $73.8 $79,031 - $91,290
1,237 Added 9.62%
14,089 $984,000
Q3 2020

Nov 10, 2020

BUY
$63.69 - $70.22 $22,482 - $24,787
353 Added 2.82%
12,852 $892,000
Q2 2020

Aug 06, 2020

BUY
$58.54 - $67.94 $64,686 - $75,073
1,105 Added 9.7%
12,499 $818,000
Q1 2020

May 11, 2020

BUY
$49.46 - $64.78 $314,367 - $411,741
6,356 Added 126.16%
11,394 $686,000
Q4 2019

Feb 10, 2020

BUY
$49.86 - $58.26 $66,762 - $78,010
1,339 Added 36.2%
5,038 $292,000
Q3 2019

Nov 05, 2019

BUY
$47.54 - $53.43 $175,850 - $197,637
3,699 New
3,699 $191,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Gw&K Investment Management, LLC Portfolio

Follow Gw&K Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.